MedPath

成都诺和晟鸿生物制药有限公司

Ownership
-
Established
2021-09-01
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

NMPA:3

Drug Approvals

Bromhexine Hydrochloride Oral Solution

Product Name
盐酸溴己新口服溶液
Approval Number
国药准字H20254457
Approval Date
Jun 3, 2025
NMPA

Carbetocin Injection

Product Name
卡贝缩宫素注射液
Approval Number
国药准字H20249486
Approval Date
Dec 1, 2024
NMPA

Desmopressin Injection

Product Name
注射用醋酸去氨加压素
Approval Number
国药准字H20234711
Approval Date
Dec 29, 2023
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.